Programme
View the 2019 Scientific Programme
08:00
Session starts at 08:00
Session starts at 08:00
WG2.1
08:24
Session starts at 08:00
Session starts at 08:00
WG2.2
EU vs. non-EU practices on Insulin Resistance assessment (ESPE ObWG project)
08:48
Session starts at 08:00
Session starts at 08:00
WG2.3
Insulin function in obese children within the low and high ranges of impaired fasting glycemia
09:12
Session starts at 08:00
Session starts at 08:00
WG2.4
09:36
Session starts at 08:00
Session starts at 08:00
WG2.5
08:05
Session starts at 08:00
Session starts at 08:00
WG1.1
08:45
Session starts at 08:00
Session starts at 08:00
WG1.3
09:05
Session starts at 08:00
Session starts at 08:00
WG1.4
09:25
Session starts at 08:00
Session starts at 08:00
WG1.5
09:35
Session starts at 08:00
Session starts at 08:00
WG1.6
08:30
Session starts at 08:00
Session starts at 08:00
WG3.3
Mechanisms of vascular calcification and potential treatment implications
09:25
Session starts at 08:00
Session starts at 08:00
WG3.6
08:25
Session starts at 08:00
Session starts at 08:00
WG4.2
09:20
Session starts at 08:00
Session starts at 08:00
WG4.5
Time in Range (TIR) - Highlights from the consensus meeting February 2019
09:40
Session starts at 08:00
Session starts at 08:00
WG4.6
HALL A
Session starts at 10:45
PL1
HALL B
Session starts at 12:00
S1.1
HALL B
Session starts at 12:00
S1.3
New developments for treatments in monogenic disorders focusing on setmelanotide trials
Karine Clement
(Paris France)
E1
Session starts at 12:00
S2.1
Longitudinal bone growth: fundamental mechanisms to clinical applications
Jeffrey Baron
(Bethesda, USA)
E1
Session starts at 12:00
S2.2
E1
Session starts at 12:00
S2.3
HALL A
Session starts at 12:00
S3.1
HALL A
Session starts at 12:00
S3.2
HALL A
Session starts at 12:00
S3.3
HALL C
Session starts at 12:00
S4.1
HALL C
Session starts at 12:00
S4.2
HALL C
Session starts at 12:00
S4.3
E2
Session starts at 12:00
ACT1.1
Online learning project for Resource Limited Countries (RLC) Introduction
Annemieke Boot
(Groningen, The Netherlands)
E2
Session starts at 12:00
ACT1.2
HALL B
Session starts at 14:45
MTE1.1
HALL C
Session starts at 14:45
MTE2.1
The interpretation of abnormal thyroid function tests in children and adolescents
Carla Moran
(Cambridge, UK)
14:45
HALL A
Session starts at 14:45
HALL A
Session starts at 14:45
HDI1.1
15:15
HALL A
Session starts at 14:45
HALL A
Session starts at 14:45
HDI1.2
What should we do with Prader Willi and GH at transition - do they benefit as adults?
Maithé Tauber
(Toulouse, France)
15:45
HALL A
Session starts at 14:45
HALL A
Session starts at 14:45
HDI1.3
HALL A
Session starts at 16:30
PL2
HALL B
Session starts at 17:00
MTE3.1
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
Claus Højbjerg Gravholt
(Aarhus, Denmark)
HALL C
Session starts at 17:00
MTE4.1